IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS | Patent Publication Number 20220144925
US 20220144925 A1
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.